)
Amneal Pharmaceuticals (AMRX) investor relations material
Amneal Pharmaceuticals EGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
The meeting was called to order at 9:00 A.M. and conducted virtually, with rules of conduct and agenda provided on the meeting website.
Participants were instructed to limit questions to items being voted on and to follow meeting procedures.
Specific resolutions to be voted on
Approval of the Membership Interest Purchase Agreement for the acquisition of 100% of Kashiv BioSciences, LLC.
Approval of the issuance of 28,942,108 shares of Class A common stock to sellers in connection with the acquisition, in compliance with Nasdaq rules.
Proposal to adjourn the meeting under certain circumstances, though not necessary to consider at this meeting.
Board and executive committee updates
The Independent Committee and Board of Directors unanimously recommended voting in favor of both the transaction and stock issuance proposals.
- Shareholders to vote on a transformative biosimilar acquisition with global growth ambitions.AMRX
Proxy filing - Q2 2026 saw 10% revenue growth, raised guidance, and a major biosimilar acquisition pending.AMRX
Q2 2026 - Biosimilars, GLP-1, and specialty drugs drive growth amid disciplined investment and integration.AMRX
Goldman Sachs 46th Annual Global Healthcare Conference - Shareholders to vote on Amneal's $375M cash and stock acquisition of Kashiv, expanding biosimilars.AMRX
Proxy filing - Shareholders to vote on $375M cash-and-stock acquisition of Kashiv BioSciences, expanding biosimilars.AMRX
Proxy filing - Biosimilars, specialty launches, and strategic partnerships drive robust long-term growth.AMRX
Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Acquisition of Kashiv BioSciences drives biosimilars leadership and strong financial growth.AMRX
Q1 2026 & M&A announcement - Momentum in generics, specialty, and biosimilars drives growth and profitability into 2026.AMRX
Barclays 28th Annual Global Healthcare Conference - Q2 revenue up 17%, guidance raised, CREXONT® FDA approved, and net leverage improved.AMRX
Q2 2024
Next Amneal Pharmaceuticals earnings date
Next Amneal Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage